| Value | ₹1.27 Cr |
|---|
BSE filing, NSE: CHOICEIN. Summary written from the filing by ALFA Finder's alert engine.
Choice International Ltd: key numbers
- Share price
- ₹744.00
- Market cap
- ₹16,575 Cr
- Revenue (annual)
- ₹1,119 Cr
- Net profit (annual)
- ₹217.7 Cr
- P/E (TTM)
- 64.7×Sector 19.4×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 9.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choice International Ltd
All →Choice International Acquisition
Choice International acquired 100% stakes in Truestock Universe and Quanthm Bit Works for Rs.10,000 each, entering digital/technology space. Its material subsidiary CCSPL also sold its entire stake in SKP Green Ventures, making it a step-down subsidiary.
Choice International Earnings Call Transcript: Key Takeaways
Record consolidated revenue of ₹379 Cr (+33%) and PAT of ~₹70 Cr (+23%) at a 34.5% EBITDA margin. Growth was partly IPO-led, and regulatory and NBFC funding-cost risks were acknowledged but not quantified.
Choice International Results Update
Choice International reported record Q2 FY27 consolidated revenue of ₹379 crore, up 33% year-on-year. Net profit rose 23% to ₹69.47 crore.
Choice International Investor Presentation: Key Takeaways
Q2 FY27: Revenue ₹379 Cr (+33% YoY), EBITDA ₹131 Cr (+32%), PAT ₹69.5 Cr (+23%). Diversified broking, advisory, wealth, insurance and NBFC platform; ₹900 Cr NH Investment infusion received.
Choice International Bonus Issue
Choice International approved a 1:1 bonus issue, subject to shareholder approval. It also proposed increasing authorised capital and convening an EGM.
Choice International Q2 FY27 Results: Net Profit ₹69.5 Cr, Up 23.0% YoY
Choice International Ltd reported revenue from operations of ₹372.9 Cr (+35.9% YoY) and net profit of ₹69.5 Cr (+23.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69.5 Cr · +23.0% YoY
Other merger & restructuring announcements
All →Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr
Saregama India Merger & Restructuring
Saregama India's board approved closing its wholly owned Dubai subsidiary, Saregama FZE, which has no ongoing operations. The closure is not expected to materially affect business operations.
Jindal Poly Films Merger & Restructuring
Jindal Poly Films' step-down subsidiary, JPF API Laminates UK Limited, was dissolved effective November 3, 2026. It has ceased to be a subsidiary of the company.
Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹2.1 Cr
Clean Max Enviro will incorporate a wholly owned IFSC subsidiary for Global Treasury Centre activities. It will subscribe 21,00,000 shares for ₹2.10 Crore in cash.
- Value
- ₹2.10 Cr